Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19
- PMID: 34491498
- PMCID: PMC8422837
- DOI: 10.1007/s11356-021-16280-5
Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19
Abstract
Coronavirus disease (COVID-19) has been declared as a pandemic by the World Health Organization with rapid spread across 216 countries. COVID-19 pandemic has left its imprints on various health systems globally and caused immense social and economic disruptions. The scientific community across the globe is in a quest for digging the effective treatment for COVID-19 and exploring potential leads from traditional systems of healthcare across the world too. Ayurveda (Indian traditional system of medicine) has a comprehensive aspect of immunity through Rasayana which is a rejuvenation therapy. Here we attempt to generate the potential leads based on the classical text from Ayurveda in general and Rasayana in particular to develop effective antiviral and/or immunomodulator for potential or adjunct therapy in SARS-CoV-2. The Rasayana acts not only by resisting body to restrain or withstand the strength, severity or progression of a disease but also by promoting power of the body to prevent the manifestation of a disease. These Rasayana herbs are common in practice as immunomodulator, antiviral and protectives. The studies on Rasayana can provide an insight into the future course of research for the plausible development of effective management of COVID-19 by the utilization and development of various traditional systems of healthcare. Keeping in view the current pandemic situation, there is an urgent need of developing potential medicines. This study proposes certain prominent medicinal plants which may be further studied for drug development process and also in clinical setup under repurposing of these herbs.
Keywords: AYUSH; Antiviral; Immunity; Repurposing; Traditional medicine.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Exploring scientific validation of Triphala Rasayana in ayurveda as a source of rejuvenation for contemporary healthcare: An update.J Ethnopharmacol. 2021 Jun 12;273:113829. doi: 10.1016/j.jep.2021.113829. Epub 2021 Jan 17. J Ethnopharmacol. 2021. PMID: 33465446 Review.
-
An Insight of Clinical Evidence of Ayurveda Interventions in the Management of COVID-19 Patients.Infect Disord Drug Targets. 2022;22(6):e210322202491. doi: 10.2174/1871526522666220321152504. Infect Disord Drug Targets. 2022. PMID: 35319399
-
Preventive aspect of ayurveda and yoga towards newly emerging disease COVID-19.J Complement Integr Med. 2021 Jan 27;18(4):667-678. doi: 10.1515/jcim-2020-0175. J Complement Integr Med. 2021. PMID: 33544526 Review.
-
Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics.Pharm Nanotechnol. 2020;8(6):437-451. doi: 10.2174/2211738508666201016151850. Pharm Nanotechnol. 2020. PMID: 33069206 Review.
-
Immunity against COVID-19: Potential role of Ayush Kwath.J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100350. doi: 10.1016/j.jaim.2020.08.003. Epub 2020 Aug 17. J Ayurveda Integr Med. 2022. PMID: 32837101 Free PMC article. Review.
Cited by
-
In Vitro Antiviral Activity of Potential Medicinal Plant Extracts Against Dengue and Chikungunya Viruses.Front Cell Infect Microbiol. 2022 Apr 7;12:866452. doi: 10.3389/fcimb.2022.866452. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35463636 Free PMC article.
-
Eco-sustainable chromatographic method for the determination of favipiravir and nitazoxanide for COVID-19: application to human plasma.BMC Chem. 2025 Jan 9;19(1):11. doi: 10.1186/s13065-024-01364-3. BMC Chem. 2025. PMID: 39789629 Free PMC article.
-
Immunomodulatory and AntiOxidant Potential of Polyherbal Dhatryadi Rasayana in the Form of Churna and Granules.ACS Omega. 2024 Mar 19;9(13):14781-14790. doi: 10.1021/acsomega.3c06784. eCollection 2024 Apr 2. ACS Omega. 2024. PMID: 38585048 Free PMC article.
-
Covid-19 and female sex workers in India: a journey of brutal reality.SN Soc Sci. 2023;3(3):53. doi: 10.1007/s43545-023-00631-9. Epub 2023 Mar 6. SN Soc Sci. 2023. PMID: 36908485 Free PMC article. Review.
-
Safety Study and Compositional Analysis of the Svarnvir-IV Tablet With Special Reference to Its Therapeutic Utility in SARS-CoV-2.Cureus. 2024 Dec 10;16(12):e75438. doi: 10.7759/cureus.75438. eCollection 2024 Dec. Cureus. 2024. PMID: 39791040 Free PMC article.
References
-
- (FEEDAP) EP on A and P or S used in AF Scientific opinion on the safety and efficacy of glycyrrhizic acid ammoniated (chemical group 30, miscellaneous substances) when used as a flavouring for all animal species. EFSA J. 2015;13:3971. doi: 10.2903/j.efsa.2015.3971. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous